Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.

Jong-In ChangDong Hyun SinnHyun ChoSeonwoo KimWonseok KangGeum-Youn GwakYong-Han PaikMoon Seok ChoiJoon Hyeok LeeKwang Cheol KohSeung Woon Paik

Published in: Digestive diseases and sciences (2021)

More than half of AVT-naïve patients experienced HBV reactivation within three years, which was associated with increased risk of overall mortality. The risk of HBV reactivation was lower for those receiving AVT, suggesting that prompt AVT needs to be considered for AVT naïve HBV-related HCC patients with undetectable HBV DNA levels.

Keyphrases

hepatitis b virus
liver failure
circulating tumor
end stage renal disease
newly diagnosed
ejection fraction
cell free
prognostic factors
cardiovascular events
patient reported outcomes
drug induced